WHO: Development of a COVID-19 vaccine delayed



[ad_1]

WHO: Development of a COVID-19 vaccine delayed

All data obtained during trials of a coronavirus vaccine should be made public and compared with each other, says the WHO.

To date, none of the coronavirus vaccines created has shown the desired effect in the second and third stages of the trials.

Mass vaccination against COVID-19 in the world will not begin before mid-2021. This was announced on Friday, September 4, by the representative of the World Health Organization Margaret Harris, reports Reuters.

To date, none of the vaccines created against the coronavirus have shown the desired effect: in the second and third stages of the trials, the effectiveness of all existing drugs was less than 50%.

“We really don’t expect mass vaccines until the middle of next year. The third phase of the trials should take longer because we need to see how much the vaccine protects against the disease and how safe it is,” Harris said.

All data obtained during trials of a coronavirus vaccine should be made public and compared with each other, the WHO spokeswoman said.

“Many people have already been vaccinated, but we still don’t know if the vaccine works. At this stage, we don’t have a clear signal of how effective and safe it is,” Harris said.

Recall that 71.5% of those surveyed in 20 countries in the world voluntarily agree to receive a vaccine against the coronavirus. At the same time, on the recommendation of the employer, only 61.4% of respondents are ready to get vaccinated against the coronavirus.

News of Correspondent.net on Telegram. Subscribe to our channel https://t.me/korrespondentnet

[ad_2]